Corundum Systems Biology

The name combines 'corundum', a hard mineral used in industrial and scientific applications, with 'systems biology', a field that uses computational modeling to study complex biological systems. This suggests the firm prioritizes startups that apply quantitative, AI-driven, or network-based methods to biology, rather than traditional biotech development paths.

Altss research indicates the firm focuses on early-stage investments, specifically startup and seed to Series A phases. Later-stage participation has not been documented.

While a public portfolio has not been disclosed, the firm's stated focus on systems biology implies active interest in life sciences, digital health, and AI/ML applied to biology. This likely includes computational therapeutics, genomics platforms, and biological data infrastructure.

The firm is headquartered in Tokyo, and its primary deal flow is assumed to be Japan-centric. There is no public record confirming dedicated offices or funds for other Asian geographies, though early-stage Japanese investors occasionally participate in pan-Asian syndicates.

The firm has not publicly disclosed its founding team or investment committee. The scientific nameplate suggests leadership with deep domain expertise in biology, computation, or both, but no principals have been confirmed through corporate registries or press.